SCHEMBL30747130

SCHEMBL30747130

O=C1CC[C@H](N2Cc3ccc(N4CCC(CO)CC4)cc3C2=O)C(=O)N1

nearest known ligand 0.63

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 20/20 0.63
▸ ESR1 P03372 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24046445 1.00 CRBN (0.63) CRBNESR1
SCHEMBL30646886 1.00 CRBN (0.63) CRBNESR1
SCHEMBL29614668 1.00 CRBN (0.63) CRBNESR1
SCHEMBL26649398 1.00 CRBN (0.63) CRBNESR1
SCHEMBL26658534 1.00 CRBN (0.63) CRBNESR1
SCHEMBL26658634 0.94 CRBN (0.61) CRBN
SCHEMBL30646867 0.94 CRBN (0.61) CRBN
SCHEMBL26658628 0.94 CRBN (0.61) CRBN
SCHEMBL20234982 0.92 CRBN (0.63) CRBNESR1
SCHEMBL29614522 0.92 CRBN (0.63) CRBNESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4522621-A1 6,6A,7,8,9,10-HEXAHYDRO-5H-PYRAZINO[1',2':4,5]PYRAZINO[2,3-C]PYRIDAZINE DERIVATIVES AS SMARCA4 PROTEIN DEGRADERS FOR THE TREATMENT OF CANCER Prelude Therapeutics Incorporated (US) 2025-03-19 — — EP disclosed
WO-2023220577-A1 6,6A,7,8,9,10-HEXAHYDRO-5H-PYRAZINO[1',2':4,5]PYRAZINO[2,3-C]PYRIDAZINE DERIVATIVES AS SMARCA4 PROTEIN DEGRADERS FOR THE TREATMENT OF CANCER PRELUDE THERAPEUTICS, INCORPORATED (US) 2023-11-16 — — WO disclosed
Send feedback